AlphaCentric Life Sciences and Healthcare Fund (LYFAX) is an MF managed by Independent / Boutique. Its largest position is FIRST AMERICAN TREASURY OBLIGA (FXFXX), representing 7.72% of fund assets.
AlphaCentric Life Sciences and Healthcare Fund Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- LYFAX
- Type:
- MF
- Manager:
- Independent / Boutique
- Total Assets:
- —
- Report Date:
- Mar 31, 2026
- Filing Date:
- May 29, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
FIRST AMERICAN TREASURY OBLIGA
|
7.72% | $3,035,292.53 | 3,035,293 |
|
-
GILEAD SCIENCES, INC.
|
7.18% | $2,823,636.20 | 20,260 |
|
-
ASTRAZENECA PLC
|
5.63% | $2,215,175.04 | 11,232 |
|
-
VERTEX PHARMACEUTICALS INC / MA
|
5.60% | $2,201,888.74 | 4,931 |
|
-
IONIS PHARMACEUTICALS INC
|
3.74% | $1,470,787.83 | 19,587 |
|
-
INSMED Inc
|
3.57% | $1,403,492.16 | 8,583 |
|
-
INCYTE CORP
|
3.41% | $1,340,739.40 | 14,245 |
|
-
Roivant Sciences Ltd.
|
3.36% | $1,320,375.90 | 47,667 |
|
-
ARGENX SE
|
3.33% | $1,310,068.50 | 1,794 |
|
-
NEUROCRINE BIOSCIENCES INC
|
3.22% | $1,265,626.18 | 9,607 |
|
-
Axsome Therapeutics, Inc.
|
2.77% | $1,088,150.76 | 6,438 |
|
-
Ascendis Pharma A/S
|
2.63% | $1,035,231.98 | 4,526 |
|
-
APOGEE THERAPEUTICS INC
|
2.43% | $956,928.73 | 11,369 |
|
-
Protagonist Therapeutics, Inc
|
2.42% | $952,816.00 | 9,040 |
|
-
AMGEN INC
|
2.08% | $819,458.65 | 2,329 |
|
-
RHYTHM PHARMACEUTICALS, INC.
|
2.06% | $808,560.09 | 9,297 |
|
-
AbbVie Inc.
|
1.96% | $770,784.56 | 3,544 |
|
-
BIOGEN INC.
|
1.79% | $703,070.55 | 3,835 |
|
-
Sanofi
|
1.76% | $692,924.76 | 14,382 |
|
-
Jazz Pharmaceuticals plc
|
1.71% | $673,207.05 | 3,561 |
|
-
CATALYST PHARMACEUTICALS INC
|
1.47% | $576,561.36 | 23,286 |
|
-
Oruka Therapeutics, Inc.
|
1.44% | $564,369.30 | 11,506 |
|
-
BioNTech SE
|
1.27% | $499,150.08 | 5,616 |
|
-
Krystal Biotech, Inc.
|
1.26% | $495,457.76 | 1,918 |
|
-
Edgewise Therapeutics, Inc.
|
1.25% | $491,872.50 | 15,615 |
|
-
NUVALENT INC-A
|
1.21% | $477,109.65 | 4,657 |
|
-
AGIOS PHARMACEUTICALS, INC.
|
1.20% | $472,638.93 | 13,971 |
|
-
NewAmsterdam Pharma Co N.V.
|
1.19% | $469,138.56 | 14,656 |
|
-
MeiraGTx Holdings plc
|
1.18% | $464,990.04 | 53,694 |
|
-
ALNYLAM PHARMACEUTICALS, INC.
|
1.15% | $453,291.90 | 1,370 |
|
-
Kymera Therapeutics, Inc.
|
1.13% | $444,935.18 | 5,342 |
|
-
Personalis, Inc.
|
1.04% | $407,883.84 | 64,032 |
|
-
Celldex Therapeutics, Inc.
|
1.02% | $400,116.08 | 12,614 |
|
-
Nurix Therapeutics, Inc.
|
1.01% | $396,350.50 | 25,571 |
|
-
Abivax S.A.
|
0.97% | $381,262.40 | 3,424 |
|
-
CYTOKINETICS INC
|
0.94% | $370,150.56 | 5,616 |
|
-
Spyre Therapeutics, Inc.
|
0.85% | $334,618.96 | 6,634 |
|
-
HALOZYME THERAPEUTICS, INC.
|
0.79% | $309,836.22 | 4,794 |
|
-
Cullinan Therapeutics, Inc.
|
0.73% | $286,118.35 | 20,135 |
|
-
Trevi Therapeutics, Inc.
|
0.73% | $285,962.10 | 23,970 |
|
-
Natera, Inc.
|
0.70% | $273,986.30 | 1,370 |
|
-
Xeris Biopharma Holdings, Inc.
|
0.68% | $266,138.80 | 45,886 |
|
-
Disc Medicine, Inc.
|
0.65% | $253,969.68 | 3,972 |
|
-
Design Therapeutics, Inc.
|
0.57% | $225,897.84 | 21,231 |
|
-
VERACYTE, INC.
|
0.56% | $220,251.98 | 6,838 |
|
-
Rezolute, Inc.
|
0.55% | $217,242.35 | 71,227 |
|
-
Tectonic Therapeutic, Inc.
|
0.54% | $211,702.59 | 6,849 |
|
-
Wave Life Sciences, Inc.
|
0.54% | $211,518.75 | 29,175 |
|
-
Monte Rosa Therapeutics, Inc.
|
0.53% | $206,710.70 | 12,566 |
|
-
Rapport Therapeutics, Inc.
|
0.51% | $201,445.02 | 6,438 |
Advertisement (320x50)